异构格兰丁促进心房心肌细胞中的线粒体功能障碍和电生理异常
Tuerdi Subati1, Zhenjiang Yang1, Matthew B Murphy1
1Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Cells
|March 27, 2024
概括
氧化应激产物 - - 异黄素 (IsoLGs) 通过损害心肌细胞功能和线粒体健康,促进心房动. 一种除尘剂,2-基乙胺 (2-HOBA),可以防止这些有害影响.
科学领域:
- 心脏病学 心脏病学
- 生物化学 生物化学
- 分子生物学分子生物学
背景情况:
- 心房动 (AF) 是一种常见的心律失常,其潜在机制尚不清楚.
- 绝缘维格兰丁 (IsoLGs) 是与氧化应激损伤相关的反应性脂质二碳基.
- 一种除尘剂,2-基二胺 (2-HOBA),以前在高血压小鼠中降低了AF易感性.
研究的目的:
- 调查IsoLGs是否有助于心房病理生理学促进AF.
- 探索IsoLGs对心房心肌细胞的细胞和分子效应.
- 评估2-HOBA对IsoLG诱导的损伤的保护潜力.
主要方法:
- 海马XFp细胞外流量分析和发光测试测量了ATP的产量.
- 线粒体功能通过膜潜力,ROS产生,蛋白质碳化和mtDNA损伤来评估.
- 补丁电生理学评估了响应IsoLGs的动作潜力变化.
主要成果:
- 暴露于IsoLG抑制了ATP的产生,并诱导了线粒体功能障碍,包括增加了ROS和mtDNA损伤.
- IsoLGs产生了细胞质的前amyloid oligomers,并迅速改变了心房动作潜力.
- 2-HOBA治疗减轻或预防了IsoLG诱导的线粒体和电生理学异常.
结论:
- IsoLGs是氧化应激的新型调解者,有助于心房病理生理学和AF.
- 由IsoLG诱导的线粒体功能障碍和电生理学变化促进AF基质.
- 像2-HOBA这样的二乙烯清洁剂代表了预防AF的潜在治疗策略.
相关概念视频
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
988
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
988
01:26Heart Failure Drugs: Inotropic Agents
578
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
578
01:28Mechanism of Cardiac Arrhythmias
918
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
918
01:48ATP Synthase: Mechanism
14.6K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.6K
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K